Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-015580
Filing Date
2022-05-27
Accepted
2022-05-27 16:12:36
Documents
2
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165368233570242.html 4  
1 FORM 4 wf-form4_165368233570242.xml 4 3904
2 FUHRMAN POA ex-24.htm EX-24 3956
  Complete submission text file 0001628280-22-015580.txt   9340
Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Fuhrman Alan (Reporting) CIK: 0001303521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 22977571

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations